Apnimed Announces $62.5 Million Series C Financing To Advance Development Of Novel Pharmaceutical Treatments For Obstructive Sleep Apnea (Osa) And Related Sleep Disorders
Amount Raised
$62.5 Million
Round Type
Series C
CambridgeManufacturingHealthcareDescription
Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related disorders, announced today that it has raised $62.5 million of committed capital in a Series C financing. New investor, Sectoral Asset Management, led the round. Also participating were new investors Alpha Wave Ventures, NexPoint, and others, joining existing investors Morningside Ventures, Seligman Investments, and Tao Capital Partners.
Quick answer
Apnimed raised $62.5 Million in a Series C round, dated May 4, 2022. Apnimed is based in Cambridge, Massachusetts, United States.
- How much did Apnimed raise?
- Apnimed raised $62.5 Million in a Series C round on May 4, 2022.
- What does Apnimed do?
- Apnimed is a clinical-stage pharmaceutical company working to transform the treatment of sleep apnea based on a simple idea – patients with obstructive sleep apnea could benefit from treatment with a safe and effective..
- Where is Apnimed based and how big is it?
- Apnimed is based in Cambridge, Massachusetts, United States. Fundz records about 82 employees.
- Who are the decision-makers at Apnimed?
- Fundz holds 1 contact at Apnimed. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Manufacturing around the same time
Companies in the same sectors as Apnimed that raised within 45 days of this round, from Fundz verified event records.
- Resilience raised $625M (Series D) on June 6, 2022.
- Trethera raised $3.8M (Seed) on May 17, 2022.
- Doc.com raised an undisclosed amount on May 3, 2022.
- Treace raised $150M (Debt Financing) on May 2, 2022.
- The Cannabist Company Holdings raised $48M on April 28, 2022.
- ROM Technologies raised $201K (Seed) on April 26, 2022.
Who to call at Apnimed, and when
A new round usually means Apnimed is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Apnimed raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Apnimed, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Apnimed. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Apnimed raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Apnimed raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.